• HBsAg kinetics in chronic hepatitis D during interferon therapy: on-treatment prediction of response 

      Niro G.A., Smedile A., Fontana R., Olivero A., Ciancio A., Valvano M.R., Pittaluga F., Coppola N., Wedemeyer H., Zachou K., Marrone A., Fasano M., Lotti G., Andreone P., Iacobellis A., Andriulli A., Rizzetto M. (2016)
      Background: Therapy of chronic hepatitis D with Interferon is successful when testing for HDV-RNA turns negative. This end-point is disputed. Aim: To assess the role of serum hepatitis B surface antigen (HBsAg) in the ...